Skip to main content
logo
Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
5.49
-0.14 (-2.49%)
At close: Oct 1, 2026, 4:00 PM EDT
5.50
+0.01 (0.18%)
After-hours: Oct 1, 2026, 7:30 PM EDT

Aligos Therapeutics Revenue

Aligos Therapeutics had revenue of $27.78M in the quarter ending June 30, 2026, with 2,778.55% growth. This brings the company's revenue in the last twelve months to $31.52M, up 893.01% year-over-year. In the year 2025, Aligos Therapeutics had annual revenue of $2.19M, down -44.59%.

Revenue (ttm)
$31.52M
Revenue Growth
+893.01%
P/S Ratio
1.09
Revenue / Employee
$384,366
Employees
82
Market Cap
34.28M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20252.19M-1.76M-44.59%
Dec 31, 20243.95M-11.58M-74.60%
Dec 31, 202315.53M1.62M11.66%
Dec 31, 202213.91M9.55M219.04%
Dec 31, 20214.36M--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Actinium Pharmaceuticals35.09M
Celularity26.55M
Immutep13.79M
Seres Therapeutics1.88M
BeyondSpring1.88M
Revenue Rankings

ALGS News

More News